Skip to main content
Top

Drugs

Issue 2/2017

Content (9 Articles)

PARP Inhibitors in Reproductive System Cancers: Current Use and Developments

  • Open Access
  • Leading Article

Geraldine O’Sullivan Coyne, Alice P. Chen, Robert Meehan, James H. Doroshow

Genotype 3 Infection: The Last Stand of Hepatitis C Virus

  • Therapy in Practice

Austin Chan, Keyur Patel, Susanna Naggie

Treating HIV Infection in the Central Nervous System

  • Review Article

A. Calcagno, G. Di Perri, S. Bonora

Mucosal Healing in Ulcerative Colitis: A Comprehensive Review

  • Review Article

Pedro Boal Carvalho, José Cotter

Sedative Effects of Levocetirizine: A Systematic Review and Meta-Analysis of Randomized Controlled Studies

  • Systematic Review

Kornkiat Snidvongs, Kachorn Seresirikachorn, Likhit Khattiyawittayakun, Wirach Chitsuthipakorn

Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease

  • Adis Drug Evaluation

Gillian M. Keating

Sitagliptin: A Review in Type 2 Diabetes

  • Adis Drug Evaluation

Lesley J. Scott

Ibrutinib: A Review in Chronic Lymphocytic Leukaemia

  • Adis Drug Evaluation

Emma D. Deeks

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images